Bumper Offer - Urjas oil Just @ Rs. 1
Levesam 1000 Tablet XR (10) is a prescription medicine that is available as a Tablet. It is typically used for the treatment of Epilepsy. Secondary and off-label uses of Levesam 1000 Tablet XR (10) have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Levesam 1000 Tablet XR (10). Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
The side effects typically associated with Levesam 1000 Tablet XR (10) include Fatigue, Headache, Drowsiness. Besides the aforementioned side effects, there are other adverse effects of Levesam 1000 Tablet XR (10) as well, which are listed below. Usually, these side effects of Levesam 1000 Tablet XR (10) go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Levesam 1000 Tablet XR (10) is Moderate for pregnant women and Mild for women who are breastfeeding. Warnings related to Levesam 1000 Tablet XR (10)'s effects on the liver, heart and kidney, if any, have been listed below.
The section on Levesam 1000 Tablet XR (10) contraindications lists all such conditions.
Drug reaction of Levesam 1000 Tablet XR (10) with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Levesam 1000 Tablet XR (10), it is important to know that it is not safe while driving, and is not habit-forming.
Levesam 1000 Tablet XR (10) is used to treat the following -
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Levesam 1000 Tablet XR (10) is used -
Moderate
Mild
Common
Is the use of Levesam 1000 Tablet XR (10) safe for pregnant women?
Pregnant women may experience moderate side effects from Levesam. It is best to stop taking Levesam immediately and inform your doctor if you notice any discomfort.
Is the use of Levesam 1000 Tablet XR (10) safe during breastfeeding?
Levesam may have very limited harmful effects for breastfeeding women.
What is the effect of Levesam 1000 Tablet XR (10) on the Kidneys?
Very few cases of side effects of Levesam on kidney have been reported.
What is the effect of Levesam 1000 Tablet XR (10) on the Liver?
Levesam has very mild side effects on the liver.
What is the effect of Levesam 1000 Tablet XR (10) on the Heart?
Levesam is not harmful for the heart.
Levesam 1000 Tablet XR (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Levesam 1000 Tablet XR (10) unless your doctor advises you to do so -
Is this Levesam 1000 Tablet XR (10) habit forming or addictive?
Levesam 1000 Tablet XR (10) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Levesam 1000 Tablet XR (10) you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Levesam 1000 Tablet XR (10) is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, this Levesam 1000 Tablet XR (10) works for mental disorders.
Interaction between Food and Levesam 1000 Tablet XR (10)
You can take Levesam 1000 Tablet XR (10) with food.
Interaction between Alcohol and Levesam 1000 Tablet XR (10)
Consuming Levesam 1000 Tablet XR (10) with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
